Rising awareness of women's health issues could help drive new growth in the femtech industry: The space is expected to be worth at least $3 billion by the end of 2030. While an estimated $500 billion in yearly medical expenses are attributed to women, R&D focused specifically on their health has lagged, creating a large market opportunity for venture capital investment.
In our latest analyst note, we focus on companies devoted to creating female health products and services. Among the findings:
VC funding in femtech has steadily increased since 2011, topping $620 million in 2018
New approaches could open the door to new products and services beyond the traditional focus of fertility and pregnancy